Processa Pharmaceuticals (NASDAQ:PCSA) is a clinical-stage biopharmaceutical company developing what it calls Next Generation Cancer therapies. Its approach modifies existing FDA-approved oncology drugs to alter how they are metabolized and distributed in the body while aiming to preserve their cancer-killing activity.
Pyxis Oncology (NASDAQ:PYXS) is a clinical-stage biotechnology company developing therapeutics for solid tumors, with a focus on antibody-drug conjugates (ADCs), targeted therapies that deliver a cytotoxic payload to cancer cells. Its lead candidate, MICVO (micvotabart pelidotin), is in early-phase trials for head and neck …
Quantum X Labs (NASDAQ:QXL) is an early-stage company focused on quantum technologies. Its recent disclosures point to work spanning quantum sampling workflows and precision timing, such as atomic-clock stability, areas with potential applications in computing, sensing and measurement.
Robin Energy (NASDAQ:RBNE) operates in the shipping and energy-transportation sector. Companies in this space typically own or operate vessels that move energy-related cargoes, with results tied to charter rates and vessel utilization.
Sable Offshore (NYSE:SOC) is an independent oil and gas company based in Houston, focused on developing the Santa Ynez Unit, a federal-waters offshore-California oil and gas project. The unit had been dormant for years before Sable worked to restart production.
Sentage Holdings (NASDAQ:SNTG) operates in financial services. Its public profile is limited, and much of the available information is concentrated in quote-page summaries and regulatory filings rather than detailed third-party analysis.
SL Green Realty (NYSE:SLG) is a fully integrated real estate investment trust and Manhattan's largest office landlord, focused on acquiring, managing and maximizing the value of Manhattan commercial properties. Its portfolio includes marquee assets such as One Vanderbilt Avenue.
U.S. Bancorp has disclosed a $10 million offering of Senior Medium-Term Notes, Series EE, with a fixed interest rate of 5.45% per annum. This announcement is significant for investors seeking fixed income investments, particularly those who are open to the possibility of early redemption …
Citigroup Global Markets Holdings Inc. has announced the issuance of new callable contingent coupon equity linked securities, linked to the performance of major indices. This development is significant for investors seeking higher yield opportunities, as the securities come with unique risks and potential rewards. …
Citigroup Global Markets Holdings Inc. has announced the issuance of callable contingent coupon equity linked securities tied to the performance of major market indices. This development is significant for investors seeking higher yields, as the securities offer the potential for periodic coupon payments while …